Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

19.57 -0.30 (-1.51%)
Streaming Delayed Price Updated: 10:16 AM EDT, May 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q1 2024 ↗
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Combined General Meeting of May 16, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
A Preview Of DBV Technologies's Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023 ↗
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 7, 2024 ↗
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
News headline image
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks That Could Blast Off In December ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Present New Data at ACAAI 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming Investor Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.